Clinical Trial

Efficacy of Clonidine in Reducing Craving in Inpatients With Cocaine and Crack Use Disorder

Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated February 24, 2026 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a single-center, randomized intervention study in a volunteer population of patients with cocaine/crack use disorder to evaluate the pharmacological treatment of cocaine/crack craving, comparing the drug clonidine with the active placebo clonazepam.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-12-16.
Status change: Not Yet Recruiting → Recruiting 2026-02-20
Trial Details
NCT Number NCT07313371
Lead Sponsor University of Sao Paulo General Hospital
Conditions Cocaine Use Disorder, Crack Abuse or Dependence
Enrollment 36 participants
Start Date 2026-01-28
Primary Completion 2026-07 (estimated)
Study Completion 2027-07 (estimated)
Updated on ClinicalTrials.gov 2026-02-24